Biotech/Healthcare
Westlake Omics has completed a Pre-A++ round exclusively backed by Ruijiang Kangsheng. The funding will support further R&D in AIVC virtual cells and clinical diagnostics and accelerate commercialization.
Source: ChinaBulls — chinabulls.com
Last updated 2026-07-17
Create Account to Unlock Full Data for Free
Get access to market data, insights, backers, analytics and funding rounds.